Definium Therapeutics to release Phase 3 anxiety drug study results

September 13, 2026 5:00 PM

Definium Therapeutics, Inc. (Nasdaq: DFTX) announced it will host a webcast on September 14, 2026, to discuss topline results from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found